Inocucor Technologies Elects Bayer’s Jim Blome to Its Board

Jim Blome, president and CEO of Bayer CropScience L.P. and head of crop protection for its North American region, has joined the board of directors of Montreal-based agriculture biotech company Inocucor Technologies Inc. as independent non-executive chairman.

Inocucor’s president and CEO, Donald Marvin, a veteran of the North American bioscience industry says Blome will bring perspective from his 25 years in mainstream agriculture to Inocucor’s board.

“The range of potential customers for Inocucor’s products is huge,” Marvin says. “We want our board to reflect the perspective of all of agriculture, from the dedicated organic farmer to the mainstream production farmer who wants to increase yields from innovative technologies.”

Inocucor produces biological soil, seed and plant accelerators that improve yields, and promote healthier, more resilient soils and plants for organic farmers, greenhouse growers and mainstream production farmers. Blome says his interest in Inocucor stems from its pioneering work in biologicals for agriculture that are available to farmers now.

“Everyone in agriculture is optimistic about the potential of these cutting-edge biologicals to help create healthier soils and offer additional solutions as part of best management practices for growers,” Blome says. “Inocucor’s technology is unique because it combines mixed groups of yeasts and bacteria, rather than a single species, into one solution.”